TAN Lijie, WANG Yougang, ZHOU Bin, SI Zhuyuan. Effect of Shouhui Tongbian Capsules and Bifidobacterium Triple Viable Bacteria Capsules in treatment of senile functional constipation differentiated as deficiency of qi and yin syndrome[J]. Journal of Clinical Medicine in Practice, 2021, 25(18): 71-75, 83. DOI: 10.7619/jcmp.20210985
Citation: TAN Lijie, WANG Yougang, ZHOU Bin, SI Zhuyuan. Effect of Shouhui Tongbian Capsules and Bifidobacterium Triple Viable Bacteria Capsules in treatment of senile functional constipation differentiated as deficiency of qi and yin syndrome[J]. Journal of Clinical Medicine in Practice, 2021, 25(18): 71-75, 83. DOI: 10.7619/jcmp.20210985

Effect of Shouhui Tongbian Capsules and Bifidobacterium Triple Viable Bacteria Capsules in treatment of senile functional constipation differentiated as deficiency of qi and yin syndrome

More Information
  • Received Date: March 27, 2021
  • Available Online: October 19, 2021
  • Published Date: September 27, 2021
  •   Objective  To observe the effect of Shouhui Tongbian Capsules combined with Bifidobacterium Triple Viable Bacteria Capsules in treatment of senile functional constipation (FC) differentiated as deficiency of both qi and yin.
      Methods  A total of 183 elderly FC patients were selected as study objects and were divided into control group 1, control group 2 and study group by random number table method, with 61 patients in each group. All patients were given conventional comprehensive treatment. The control group 1 was treated with Bifidobacterium Triple Viable Bacteria Capsules, the control group 2 was treated with Shouhui Tongbian Capsules, and study group was treated with Bifidobacterium Triple Viable Bacteria Capsules combined with Shouhui Tongbian Capsules. Before and 4 weeks after treatment, TCM syndrome scores, Bristol scores and defecation difficulty scores were evaluated in the three groups. Fastening venous blood was collected in the morning to detect the levels of gastrointestinal hormones such as motilin (MTL), gastrin (GAS) and substance P (SP) in the three groups. Anorectal dynamics indexes, such as resting pressure of anal canal, systolic pressure of anal canal and maximum tolerance capacity were detected in three groups. After treatment, the incidence of adverse reactions, the recurrence rate and total effective rate of the three groups were compared.
      Results  The total effective rate of the study group was significantly higher than that of the control groups 1 and 2 (P < 0.05). There were significant differences in TCM syndrome score, defecation difficulty score, Bristol score and serum levels of MTL, GAS and SP before and after treatment among the three groups (P < 0.05). After treatment, TCM syndrome score and defecation difficulty score in the study group were significantly lower than those in control groups 1 and 2, and Bristol score, MTL, GAS and SP levels were significantly higher than those in the control groups 1 and 2(P < 0.05). After treatment, the anal canal resting pressure and anal canal systolic blood pressure in the three groups were increased compared with before treatment, and the maximum tolerance capacity was decreased compared with before treatment (P < 0.05). The anal canal resting pressure and anal canal systolic blood pressure in the study group were significantly higher than those in the control groups 1 and 2, and the maximum tolerance capacity was significantly lower than that in the control groups 1 and 2 (P < 0.05). The recurrence rate of study group was significantly lower than that of the control groups 1 and 2 (P < 0.05). There was no significant difference in the incidence of adverse drug reactions among three groups (P < 0.05).
      Conclusion  For elderly FC patients with deficiency of both qi and yin, Shouhui Tongbian Capsules combined with Bifidobacterium Triple Viable Bacteria Capsules has a relatively ideal curative effect, which can significantly improve constipation symptoms, effectively up-regulate gastrointestinal hormone levels, significantly improve anorectal dynamics, greatly reduce the recurrence rate, and has higher safety.
  • [1]
    SCHNABEL L, BUSCAIL C, SABATE J M, et al. Association Between Ultra-Processed Food Consumption and Functional Gastrointestinal Disorders: Results From the French NutriNet-Santé Cohort[J]. Am J Gastroenterol, 2018, 113(8): 1217-1228. doi: 10.1038/s41395-018-0137-1
    [2]
    魏景景, 崔颖竹. 麻仁软胶囊联合双歧杆菌乳杆菌三联活菌片治疗热积证功能性便秘的疗效观察[J]. 现代药物与临床, 2018, 33(2): 363-367. https://www.cnki.com.cn/Article/CJFDTOTAL-GWZW201802035.htm
    [3]
    彭军良, 姚向阳, 陆金根, 等. 益气开秘方治疗气阴两虚型慢传输型便秘的临床研究[J]. 上海中医药杂志, 2018, 52(11): 50-53. https://www.cnki.com.cn/Article/CJFDTOTAL-SHZZ201811019.htm
    [4]
    方秀才. 罗马Ⅳ功能性肠病诊断标准的修改对我国的影响[J]. 胃肠病学和肝病学杂志, 2017, 26(5): 481-483. doi: 10.3969/j.issn.1006-5709.2017.05.001
    [5]
    中华中医药学会. 中医内科常见病诊疗指南中医病症部分[M]. 北京: 中国中医药出版社, 2008: 86-89.
    [6]
    国家中医药管理局. 中医病证诊断疗效标准[M]. 南京: 南京大学出版社, 1994: 114-116.
    [7]
    丁杨杨, 王光绕, 彭琼, 等. 应用Bristol大便分型量表指导不同肠道准备方案的效果[J]. 胃肠病学和肝病学杂志, 2018, 27(7): 773-776. doi: 10.3969/j.issn.1006-5709.2018.07.013
    [8]
    邓罡, 徐丽姝, 覃铁和. 老年功能性便秘患者盆底表面肌电特征及生物反馈治疗[J]. 实用医学杂志, 2018, 34(8): 1316-1319. doi: 10.3969/j.issn.1006-5725.2018.08.023
    [9]
    李丽璇. 补中益气汤联合针灸治疗老年功能性便秘疗效观察[J]. 实用中西医结合临床, 2018, 18(12): 78-80. https://www.cnki.com.cn/Article/CJFDTOTAL-SZXL201812036.htm
    [10]
    裴静波, 乐芳华, 潘建锋, 等. 益气宣肺通便方对阴虚肠燥型功能性便秘患者血清炎性因子及胃肠激素的影响[J]. 中国现代医生, 2019, 57(3): 26-29, 33. https://www.cnki.com.cn/Article/CJFDTOTAL-ZDYS201903008.htm
    [11]
    梁亮, 马勇, 高文婷. 帕罗西汀联合微生态制剂治疗伴有功能性消化不良症状的焦虑障碍患者疗效[J]. 中国微生态学杂志, 2019, 31(1): 94-96. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWS201901021.htm
    [12]
    彭蕾, 万君. 四磨汤、小麦纤维素颗粒联合微生态制剂治疗婴幼儿功能性便秘的临床疗效[J]. 中国妇幼保健, 2017, 32(18): 4448-4450. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB201718047.htm
    [13]
    周峰, 张旗, 张永安, 等. 益气养阴方治疗气阴两虚型慢性功能性便秘40例[J]. 西部中医药, 2019, 32(4): 94-96. doi: 10.3969/j.issn.1004-6852.2019.04.025
    [14]
    颜桂林, 李磊, 蒲永平, 等. 杨向东教授自拟玄参汤治疗气阴两虚型慢性功能性便秘疗效观察[J]. 四川中医, 2020, 38(2): 129-132. https://www.cnki.com.cn/Article/CJFDTOTAL-SCZY202002047.htm
    [15]
    孙双玉, 缪剑辉. 自拟五仁汤治疗慢性顽固性便秘气阴两虚证临床研究[J]. 中国中医药信息杂志, 2019, 26(4): 29-33. doi: 10.3969/j.issn.1005-5304.2019.04.007
    [16]
    姜晗. 粪菌移植联合乳果糖对顽固性功能性便秘患者胃肠道功能及生活质量的影响[J]. 保健医学研究与实践, 2019(4): 63-66. https://www.cnki.com.cn/Article/CJFDTOTAL-GXBJ201904014.htm
    [17]
    KIM J E, KANG M J, CHOI J Y, et al. Regulation of gastrointestinal hormones during laxative activity of gallotannin-enriched extract isolated from Galla Rhois in loperamide-induced constipation of SD rats[J]. Lab Animal Res, 2018, 34(4): 223-231. doi: 10.5625/lar.2018.34.4.223
    [18]
    ZOUHAL H, SELLAMI M, SAEIDI A, et al. Effect of physical exercise and training on gastrointestinal hormones in populations with different weight statuses[J]. Nutr Rev, 2019, 77(7): 455-477. doi: 10.1093/nutrit/nuz005
    [19]
    匡晓雯, 郑羽翔, 龚裕菊. 济川煎在老年慢性功能性便秘患者中的临床应用疗效分析[J]. 结直肠肛门外科, 2019, 25(5): 578-583. https://www.cnki.com.cn/Article/CJFDTOTAL-DCGM201905022.htm
    [20]
    任红微, 魏静, 高秀梅, 等. 何首乌及其主要化学成分药理作用及机制研究进展[J]. 药物评价研究, 2018, 41(7): 1357-1362. https://www.cnki.com.cn/Article/CJFDTOTAL-YWPJ201807038.htm
    [21]
    杨冰, 任娟, 秦昆明, 等. 决明子药理作用及其机制研究进展[J]. 中药材, 2018, 41(5): 1247-1251. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYCA201805053.htm
  • Related Articles

    [1]MAO Tingting, JIANG Qiong, WANG Yan, MING Xia, LOU Yinghua. Correlations of serum transforming growth factor-β1 and insulin-like growth factor-1 with pathological features and postoperative recurrence in patients with adenomyosis[J]. Journal of Clinical Medicine in Practice, 2025, 29(4): 103-107. DOI: 10.7619/jcmp.20243572
    [2]HOU Guoqing, YUE Hailong, CHANG Qian, MA Juntao. Effect of dexmedetomidine on epidural fibrosis afterspinal surgery in rats via the transforming growth factor-β1 pathway[J]. Journal of Clinical Medicine in Practice, 2025, 29(1): 77-82. DOI: 10.7619/jcmp.20243181
    [3]RAN Qian, FAN Chonggui, MA Weifeng, LI Shuaiqi. Associations of serum transforming growth factor-β1 and klotho expression levels with disease severity and cognitive function in patients with epilepsy[J]. Journal of Clinical Medicine in Practice, 2025, 29(1): 56-60. DOI: 10.7619/jcmp.20241976
    [4]CUI Xiaojing, ZHAO Chunmei, YANG Bo. Expression and significance of serum insulin-like growth factor binding protein-7 and silencing information regulator 4 in patients with acute heart failure[J]. Journal of Clinical Medicine in Practice, 2024, 28(3): 74-78, 83. DOI: 10.7619/jcmp.20232118
    [5]JIANG Mingxia, WANG Yu, LYU Guilan, ZHOU Yinan, DONG Xingyuan, XU Qi, ZHENG Jinfeng. Effect of essential fatty acids by MCP-1/TGF-β1/COL-Ⅰ pathways for human kidney 2 cells with sugar damage[J]. Journal of Clinical Medicine in Practice, 2022, 26(13): 1-6, 40. DOI: 10.7619/jcmp.20220397
    [6]GUI Zhaohua, WU Jing, LI Xiaojie, YAN Hong. Expression of bone morphogenetic protein 9 and insulin-like growth factor-1 in different molecular subtypes of breast cancer and their correlations with clinical features[J]. Journal of Clinical Medicine in Practice, 2021, 25(8): 1-5, 10. DOI: 10.7619/jcmp.20210079
    [7]LI Fei, TANG Ping. Efficacy of pernasal intermittent positive pressure ventilation combined with high-dose bovine lung surfactant in the treatment of severe neonatal respiratory distress syndrome[J]. Journal of Clinical Medicine in Practice, 2020, 24(14): 71-75. DOI: 10.7619/jcmp.202014019
    [8]WANG Ruozhang, JIN Jian. Expression and purification of recombinant human bone morphogenetic protein 10 and it cardiac protection effect[J]. Journal of Clinical Medicine in Practice, 2019, 23(21): 1-6,17. DOI: 10.7619/jcmp.201921001
    [9]ZHU Chun, HUANG Haidong, WANG Lirui, GUO Zhiyong. Influence of heme oxygenase-1 on expressions of transforming growth factor-β1 and fibronectin in peritoneal mesothelial cells of rats induced by high glucose[J]. Journal of Clinical Medicine in Practice, 2014, (1): 1-4. DOI: 10.7619/jcmp.201401001
    [10]SHAO Weibin, ZHU Li, GU Lin, XIA Chunying, LI Xin, XUN Kang, FENG Songtao. Effect of bone morphogenetic protein-7 on advanced glycation end products induced epithelial-to-mesenchymal transition of rat peritoneal mesothelial cells[J]. Journal of Clinical Medicine in Practice, 2012, (22): 9-13.
  • Cited by

    Periodical cited type(7)

    1. 刘娟,王凤兰. 川崎病患儿冠状动脉病变的影响因素分析及预测模型构建. 国际医药卫生导报. 2025(01): 60-65 .
    2. 刘威,张兰. 婴儿川崎病冠状动脉病变的临床特点及危险因素分析. 分子诊断与治疗杂志. 2025(01): 38-40+45 .
    3. 徐树红,姜军. 川崎病患儿冠脉病变发生的危险因素模型构建及分析. 医学理论与实践. 2024(13): 2290-2292 .
    4. 张春燕. 白细胞介素-6/白蛋白比值与川崎病患儿冠状动脉损害的相关性研究. 中国实用医刊. 2023(11): 16-20 .
    5. 高健,陈雨青. 川崎病患儿发生血管损伤的影响因素. 血管与腔内血管外科杂志. 2023(07): 846-849+863 .
    6. 田慧,郝晓燕,祁洁,李莉,郭瑞霞,尉志红. 儿童川崎病的危险因素分析及列线图模型构建. 中西医结合心脑血管病杂志. 2023(17): 3278-3280 .
    7. 张惠,张晓斌,陈俊义. 川崎病患儿急性期血脂水平与冠脉病变关系的研究. 中国卫生标准管理. 2023(24): 23-27 .

    Other cited types(2)

Catalog

    Article views (236) PDF downloads (17) Cited by(9)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return